Jiangsu Nanfang Medical Co., Ltd. (603880.SS)
CNY 4.92
(-2.38%)
CNY 4.92
(-2.38%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 33.76 Million CNY | -22.89% |
| 2022 | 72.18 Million CNY | -33.93% |
| 2021 | 109.25 Million CNY | -69.92% |
| 2020 | 363.25 Million CNY | 242.74% |
| 2019 | 105.98 Million CNY | -5.84% |
| 2018 | 112.55 Million CNY | -12.85% |
| 2017 | 129.14 Million CNY | -1.77% |
| 2016 | 131.47 Million CNY | -2.58% |
| 2015 | 134.96 Million CNY | -0.06% |
| 2014 | 135.03 Million CNY | 2.41% |
| 2013 | 131.86 Million CNY | 26.78% |
| 2012 | 104 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 10.65 Million CNY | -39.97% |
| 2024 Q1 | 15.76 Million CNY | 196.31% |
| 2024 Q2 | 20.23 Million CNY | 28.33% |
| 2023 Q2 | 28.68 Million CNY | 7.26% |
| 2023 Q1 | 26.74 Million CNY | 295.05% |
| 2023 FY | 55.66 Million CNY | -22.89% |
| 2023 Q4 | -16.37 Million CNY | -198.53% |
| 2023 Q3 | 16.61 Million CNY | -42.07% |
| 2022 Q3 | 17.3 Million CNY | -12.31% |
| 2022 Q2 | 19.72 Million CNY | -30.51% |
| 2022 Q1 | 28.39 Million CNY | 26.34% |
| 2022 FY | 72.18 Million CNY | -33.93% |
| 2022 Q4 | 6.76 Million CNY | -60.87% |
| 2021 Q4 | 22.47 Million CNY | -16.79% |
| 2021 Q3 | 27 Million CNY | 3.97% |
| 2021 Q1 | 33.79 Million CNY | -42.83% |
| 2021 FY | 109.25 Million CNY | -69.92% |
| 2021 Q2 | 25.97 Million CNY | -23.15% |
| 2020 FY | 363.25 Million CNY | 242.74% |
| 2020 Q4 | 59.12 Million CNY | 42.85% |
| 2020 Q1 | 25.18 Million CNY | 3.43% |
| 2020 Q2 | 237.56 Million CNY | 843.45% |
| 2020 Q3 | 41.38 Million CNY | -82.58% |
| 2019 Q3 | 30.18 Million CNY | 4.28% |
| 2019 FY | 105.98 Million CNY | -5.84% |
| 2019 Q4 | 24.34 Million CNY | -19.35% |
| 2019 Q1 | 22.5 Million CNY | -5.2% |
| 2019 Q2 | 28.94 Million CNY | 28.65% |
| 2018 Q3 | 31.18 Million CNY | 14.99% |
| 2018 FY | 112.55 Million CNY | -12.85% |
| 2018 Q4 | 23.73 Million CNY | -23.89% |
| 2018 Q2 | 27.12 Million CNY | -11.09% |
| 2018 Q1 | 30.5 Million CNY | -0.3% |
| 2017 FY | 129.14 Million CNY | -1.77% |
| 2017 Q1 | 28.07 Million CNY | -11.99% |
| 2017 Q2 | 38.19 Million CNY | 36.06% |
| 2017 Q3 | 32.27 Million CNY | -15.49% |
| 2017 Q4 | 30.59 Million CNY | -5.2% |
| 2016 FY | 131.47 Million CNY | -2.58% |
| 2016 Q4 | 31.89 Million CNY | 2.92% |
| 2016 Q3 | 30.99 Million CNY | 94.3% |
| 2016 Q2 | 15.95 Million CNY | 0.0% |
| 2016 Q1 | 15.95 Million CNY | 0.0% |
| 2015 FY | 134.96 Million CNY | -0.06% |
| 2014 FY | 135.03 Million CNY | 2.41% |
| 2013 FY | 131.86 Million CNY | 26.78% |
| 2012 FY | 104 Million CNY | 0.0% |